QQQ   444.67 (-0.04%)
AAPL   170.70 (-1.51%)
MSFT   421.05 (-0.09%)
META   489.25 (-0.93%)
GOOGL   150.85 (-0.01%)
AMZN   180.85 (+0.57%)
TSLA   176.85 (-1.66%)
NVDA   908.44 (+0.66%)
NIO   4.61 (-1.28%)
AMD   181.43 (+1.02%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.24 (+1.38%)
MU   118.28 (-0.72%)
CGC   9.28 (-2.83%)
GE   175.02 (-2.83%)
DIS   122.68 (+1.41%)
AMC   3.75 (-13.59%)
PFE   27.91 (+0.47%)
PYPL   66.84 (+0.41%)
XOM   115.46 (+0.43%)
QQQ   444.67 (-0.04%)
AAPL   170.70 (-1.51%)
MSFT   421.05 (-0.09%)
META   489.25 (-0.93%)
GOOGL   150.85 (-0.01%)
AMZN   180.85 (+0.57%)
TSLA   176.85 (-1.66%)
NVDA   908.44 (+0.66%)
NIO   4.61 (-1.28%)
AMD   181.43 (+1.02%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.24 (+1.38%)
MU   118.28 (-0.72%)
CGC   9.28 (-2.83%)
GE   175.02 (-2.83%)
DIS   122.68 (+1.41%)
AMC   3.75 (-13.59%)
PFE   27.91 (+0.47%)
PYPL   66.84 (+0.41%)
XOM   115.46 (+0.43%)
QQQ   444.67 (-0.04%)
AAPL   170.70 (-1.51%)
MSFT   421.05 (-0.09%)
META   489.25 (-0.93%)
GOOGL   150.85 (-0.01%)
AMZN   180.85 (+0.57%)
TSLA   176.85 (-1.66%)
NVDA   908.44 (+0.66%)
NIO   4.61 (-1.28%)
AMD   181.43 (+1.02%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.24 (+1.38%)
MU   118.28 (-0.72%)
CGC   9.28 (-2.83%)
GE   175.02 (-2.83%)
DIS   122.68 (+1.41%)
AMC   3.75 (-13.59%)
PFE   27.91 (+0.47%)
PYPL   66.84 (+0.41%)
XOM   115.46 (+0.43%)
QQQ   444.67 (-0.04%)
AAPL   170.70 (-1.51%)
MSFT   421.05 (-0.09%)
META   489.25 (-0.93%)
GOOGL   150.85 (-0.01%)
AMZN   180.85 (+0.57%)
TSLA   176.85 (-1.66%)
NVDA   908.44 (+0.66%)
NIO   4.61 (-1.28%)
AMD   181.43 (+1.02%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.24 (+1.38%)
MU   118.28 (-0.72%)
CGC   9.28 (-2.83%)
GE   175.02 (-2.83%)
DIS   122.68 (+1.41%)
AMC   3.75 (-13.59%)
PFE   27.91 (+0.47%)
PYPL   66.84 (+0.41%)
XOM   115.46 (+0.43%)
NYSE:MD

Pediatrix Medical Group (MD) Stock Price, News & Analysis

$10.10
+0.11 (+1.10%)
(As of 11:15 AM ET)
Today's Range
$9.97
$10.15
50-Day Range
$8.46
$9.98
52-Week Range
$7.70
$15.20
Volume
56,519 shs
Average Volume
715,386 shs
Market Capitalization
$849.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.30

Pediatrix Medical Group MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
2.2% Upside
$10.30 Price Target
Short Interest
Bearish
4.85% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.61mentions of Pediatrix Medical Group in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
2.68%
From $1.12 to $1.15 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.36 out of 5 stars

Medical Sector

887th out of 939 stocks

Hospitals Industry

3rd out of 3 stocks

MD stock logo

About Pediatrix Medical Group Stock (NYSE:MD)

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

MD Stock Price History

MD Stock News Headlines

This consistently signaled gains of 453%... 610%... and even 1036%...
It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Recap: Pediatrix Medical Group Q4 Earnings
Pediatrix Medical Group Reports Fourth Quarter Results
Earnings Preview For Pediatrix Medical Group
Your Guide to Baby Sleep Regressions
See More Headlines
Receive MD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pediatrix Medical Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/20/2024
Today
3/28/2024
Next Earnings (Estimated)
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospitals
Sub-Industry
Health Care Services
CUSIP
58502B10
Employees
5,170
Year Founded
1979

Price Target and Rating

Average Stock Price Target
$10.30
High Stock Price Target
$14.00
Low Stock Price Target
$9.00
Potential Upside/Downside
+2.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

Net Income
$-60,410,000.00
Pretax Margin
-2.42%

Debt

Sales & Book Value

Annual Sales
$1.99 billion
Cash Flow
$1.65 per share
Book Value
$10.10 per share

Miscellaneous

Free Float
82,441,000
Market Cap
$849.61 million
Optionable
Optionable
Beta
1.56

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. James D. Swift M.D. (Age 62)
    CEO & Director
    Comp: $549.53k
  • Mr. C. Marc Richards (Age 53)
    Executive VP & CFO
    Comp: $509.58k
  • Ms. Mary Ann E. Moore (Age 64)
    Executive VP, General Counsel & Secretary
    Comp: $542.02k
  • Dr. Curtis B. Pickert M.D. (Age 66)
    Executive VP & COO
  • Mr. John C. PepiaMr. John C. Pepia (Age 61)
    Senior VP & Chief Accounting Officer
    Comp: $931.2k
  • Ms. Cheryl M. VanPatten
    Senior VP & Chief Information Officer
  • Mr. Daniel Patrick Corcoran
    Senior Vice President of Administration & Managed Care
  • Mr. Charles W. Lynch C.F.A.
    Senior VP of Finance, Strategy & Investor Relations
  • Ms. Meghan K. Lublin
    Senior VP, Chief Brand & Communications Officer
  • Mr. Lee A. Wood (Age 56)
    Executive Vice President of National & Market Operations

MD Stock Analysis - Frequently Asked Questions

Should I buy or sell Pediatrix Medical Group stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pediatrix Medical Group in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MD, but not buy additional shares or sell existing shares.
View MD analyst ratings
or view top-rated stocks.

What is Pediatrix Medical Group's stock price target for 2024?

4 brokers have issued 1 year price targets for Pediatrix Medical Group's shares. Their MD share price targets range from $9.00 to $14.00. On average, they expect the company's share price to reach $10.30 in the next year. This suggests a possible upside of 2.2% from the stock's current price.
View analysts price targets for MD
or view top-rated stocks among Wall Street analysts.

How have MD shares performed in 2024?

Pediatrix Medical Group's stock was trading at $9.30 at the start of the year. Since then, MD stock has increased by 8.4% and is now trading at $10.08.
View the best growth stocks for 2024 here
.

Are investors shorting Pediatrix Medical Group?

Pediatrix Medical Group saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 4,030,000 shares, an increase of 25.2% from the February 29th total of 3,220,000 shares. Based on an average daily volume of 732,700 shares, the short-interest ratio is currently 5.5 days. Approximately 4.9% of the company's stock are short sold.
View Pediatrix Medical Group's Short Interest
.

When is Pediatrix Medical Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our MD earnings forecast
.

How were Pediatrix Medical Group's earnings last quarter?

Pediatrix Medical Group, Inc. (NYSE:MD) posted its earnings results on Tuesday, February, 20th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.30 by $0.02. The company had revenue of $496.44 million for the quarter, compared to analyst estimates of $524.30 million. Pediatrix Medical Group had a negative net margin of 3.03% and a positive trailing twelve-month return on equity of 10.35%. The business's quarterly revenue was down 3.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.46 EPS.

What is Mark S. Ordan's approval rating as Pediatrix Medical Group's CEO?

6 employees have rated Pediatrix Medical Group Chief Executive Officer Mark S. Ordan on Glassdoor.com. Mark S. Ordan has an approval rating of 34% among the company's employees. This puts Mark S. Ordan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Pediatrix Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pediatrix Medical Group investors own include NVIDIA (NVDA), AbbVie (ABBV), QUALCOMM (QCOM), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), Walt Disney (DIS), Wells Fargo & Company (WFC), Exxon Mobil (XOM) and Advanced Micro Devices (AMD).

Who are Pediatrix Medical Group's major shareholders?

Pediatrix Medical Group's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (12.37%), Vanguard Group Inc. (12.36%), Dimensional Fund Advisors LP (5.25%), Pacer Advisors Inc. (3.85%), Charles Schwab Investment Management Inc. (1.94%) and Invenomic Capital Management LP (1.64%). Insiders that own company stock include James D Swift, John C Pepia, Mark S Ordan, Mary Ann E Moore, Roger Mack Hinson, Roger Md Medel and Shirley A Weis.
View institutional ownership trends
.

How do I buy shares of Pediatrix Medical Group?

Shares of MD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:MD) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners